Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2006-03-21
2006-03-21
Richter, Johann (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C562S440000, C562S457000, C564S192000, C564S180000, C564S315000
Reexamination Certificate
active
07015352
ABSTRACT:
Prodrug compounds capable of permeating a desired biological compartment and releasing a biologically active molecule in active form to effect a therapeutic functional change in the compartment to which it is introduced.
REFERENCES:
patent: 2829148 (1958-04-01), Chalkley
patent: 2839542 (1958-06-01), Chalkley
patent: 2839543 (1958-06-01), Chalkley
patent: 2855303 (1958-10-01), Chalkley
patent: 2936235 (1960-05-01), Chalkley
patent: 3798131 (1974-03-01), Rounds et al.
patent: 4399131 (1983-08-01), Durckheimer
patent: 4599303 (1986-07-01), Yabusaki et al.
patent: 4626501 (1986-12-01), Landes
patent: 4656127 (1987-04-01), Mundy
patent: 4683194 (1987-07-01), Saiki et al.
patent: 4716106 (1987-12-01), Chiswell
patent: 5428163 (1995-06-01), Mills
patent: 078636 (1985-06-01), None
patent: WO 01/95944 (2001-12-01), None
CA:113:184733 abs of WO 8909833 Oct. 1989.
CA:123:296612 abs of US 5428163 Jun. 1995.
CA:125:67247 abs of JP08073338 Mar. 1996.
Downing, D.T., et al., Biochem. Biophys. Research Comm., 40, 218-223 (1970).
Dreyer, J.F., “Self-Attenuating Opthalmic Filter”, Report WADD-TR-60-632, Feb. 1961, AD 322820.
Dreyer, J.F., et al., “Investigation of Materials and Systems for Protection Against Flash Blindness Effects of Nuclear Detonations,” Report 68-38-CM, AD 688692 (1982).
Dreyer, J.F., Polacoat Inc., Tech. Report SEG-TR-65-50, 1-40, Oct. 1965.
Dreyer, J.F., Polacoat Inc., WADD Tech. Report 60-827, Contract AF 33(616)-6715,Feb. 1-20, 1961.
Tunnicliff, G., et al. Experientia, 33, 20-22 (1977).
DeConti, Jr. Giulio A.
Lahive & Cockfield, LLP.
Puttlitz Karl
Richter Johann
Weintraub Jacob G.
LandOfFree
Pro drugs for selective drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pro drugs for selective drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro drugs for selective drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3526642